Impact of ERAS Protocol on Length of Hospital Stay After Laparoscopic Surgeries

Aga Khan University

Status and phase: Not yet enrolling; Phase 4

Conditions: ERAS

Treatments: Drug: Enhanced Recovery After Surgery; Drug: Control

Study type: Interventional

Funder types: Other

Identifiers

NCT07116564

2025-11268-35403

Details and patient eligibility

About

The goal of this clinical trial is to determine the length of hospital stay in patients using multimodal analgesia with or without ERAS protocol scheduled for elective laparoscopic gynecological surgeries

Enrollment: 98 estimated patients

Sex: Female

Ages: 20 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• ASA physical status I, II, and III
• Patients scheduled for elective laparoscopic gynecological surgeries

Exclusion criteria

• Refusal to participate
• History of allergy or contraindication to study drugs
• Patients in which procedure converted to open surgery
• Diagnostic laparoscopic procedures
• Patients with a history of severe anxiety or depression

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

98 participants in 2 patient groups

Group C

Active Comparator group

Treatment:

Drug: Control

Group E

Experimental group

Treatment:

Drug: Enhanced Recovery After Surgery